GLITTER Study: Better Blood Sugar Control in Type 1 Diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a program to help people with type 1 diabetes improve their blood sugar control using continuous glucose monitors, insulin pumps, and education sessions. It includes remote monitoring and camp activities for some participants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with type 1 diabetes
- Age 6 or older
- Able to use a continuous glucose monitor and insulin pump, and share data
- Willing to attend education sessions and possibly a camp
- No severe health issues like heart, kidney, or bleeding problems
- Not pregnant or planning pregnancy in the next year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This trial tests a program to help low-income adults with type 1 diabetes use continuous glucose monitors (CGM). You and a family member or friend will attend four weekly sessions to learn how to get the most out of the device.
This study looks at how well your blood sugar stays in the target range and whether it's linked to the health of your blood vessels and heart. You would use a continuous glucose monitor, and the results may help improve care for people with type 1 diabetes.
This study tests whether a team approach—including technology, education, and support from peers—can help people with type 1 diabetes improve their blood sugar levels. It may be a good fit if you have type 1 diabetes and are looking for extra help managing it.
This study offers a structured education course and regular checkups to help adults with type 1 diabetes better manage their blood sugar and overall health. Participants will learn about their condition and receive support to improve metabolic indicators.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.